Life Sciences Chronicle
Ogan Gurel MD
Thinking about Life Sciences: Category Archive for FDA Reform

FDA issues a "black box" warning for Avandia - A Balancing Act Between Safety and Choice

Drug Safety & FDA Reform : An Audio (.mp3) Podcast

Drug safety and FDA Reform: An Audio (.mp3) Podcast

Accelerating Medical Technology Innovation, Drug/Device Safety and FDA Reform: InTimeTV broadcast

FDA panel votes to retain Avandia on the market: DrugWonks celebrate; Prince Hal rails against Falstaff ...

InTimeTV interview. Live on Saturday, July 28th at 12noon (Central Time): Innovation, Life Sciences Accelerator, Drug Safety, FDA reform and other topics

FDA Report on Avandia: Implications and a "critique" of the critique

"Conversations in Biotechnology and other topics": InTimeTV interview

You voted on the FDA. See the results here ...

Boston Scientific, Medtronic settle some defibrillator suits; is the device safety storm over?

Avandia, the Drug Safety Debate and How to Get a Nobel Prize

Financial Incentives Can Drive New Pharmaceutical & Medical Technology Adoption: What are the Implications?

FDA Reform Redux: On Business Models, Regulatory Reform and Safety

FDA: Tortoise, Hare or Something Else

Drug /Device Safety Debate to Yield Big Changes, Grow More Controversial

Perspective Following BIO 2006: The Midwest as Innovation Central?

Tech Convergence a Key Theme at Orthopedics Conference in Chicago